Clinical trials
Observational Postoperative Complications trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 6 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ohio State University | 2 |
| University of California, San Francisco | 2 |
| University of Pittsburgh | 2 |
| University of Texas Southwestern Medical Center | 2 |
| Yale University | 2 |
| AO Clinical Investigation and Publishing Documentation | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Biotronik, Inc. | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Complications | 34 |
| Breast Neoplasms | 3 |
| Intraoperative Complications | 3 |
| Postoperative Cognitive Complications | 3 |
| Anastomotic Leak | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Delirium | 2 |
| Emergence Delirium | 2 |
| Myocardial Infarction | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.